| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Radiology, Hospital of the University of Pennsylvania, 3400
Spruce St., Philadelphia, PA 19104.
2 Department of Radiology, Massachusetts General Hospital, Institute of
Technology Assessment, 101 Merrimac St., 10th Fl., Boston, MA 02214.
3 Department of Surgery, Hospital of the University of Pennsylvania,
Philadelphia, PA 19104.
4 Department of Radiation Oncology, Hospital of the University of Pennsylvania,
Philadelphia, PA 19104.
OBJECTIVE. The aims of this study were to assess the diagnostic accuracy of MRI in evaluating patients for residual cancer, identify the prevalence of multicentric or multifocal disease, and evaluate the impact of MRI on surgical treatment planning.
SUBJECTS AND METHODS. Of 101 potentially eligible patients, 80 candidates for breast conservation therapy who had primary breast cancer in 82 breasts diagnosed by excisional biopsy with close or positive margins were included in the study group. All patients underwent contrast-enhanced MRI before further surgery and subsequently underwent either reexcision lumpectomy or mastectomy with histopathologic correlation.
RESULTS. Residual carcinoma, either invasive or in situ, was present in 59.8% of the breasts. The sensitivity and specificity of MRI for detecting residual disease were 61.2% and 69.7%, respectively. Twenty-three additional lesions distant from the biopsy site were identified in 19 breasts, and 18 suspicious lesions underwent biopsy. Histology results indicated that six lesions were malignant, so the overall prevalence was 7.3%. The positive predictive value of identifying an additional suspicious lesion was 33.3%. In 24 breasts, MRI changed which procedure would be performed next from reexcision lumpectomy to mastectomy (n = 9), biopsy of an additional lesion in the ipsilateral (n = 12) or contralateral (n = 2) breast, or neoadjuvant chemotherapy (n = 1). Approximately 25% of the breasts underwent mastectomy as definitive surgical treatment.
CONCLUSION. Overlap in the appearances of benign and malignant lesions limits MRI evaluation for residual disease. MRI can show additional suspicious lesions that are likely to be multicentric or multifocal disease. These findings changed the original treatment plan for approximately 30% of breasts.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. E. Brennan, N. Houssami, S. Lord, P. Macaskill, L. Irwig, J. M. Dixon, R. M.L. Warren, and S. Ciatto Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management J. Clin. Oncol., November 20, 2009; 27(33): 5640 - 5649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Katipamula, A. C. Degnim, T. Hoskin, J. C. Boughey, C. Loprinzi, C. S. Grant, K. R. Brandt, S. Pruthi, C. G. Chute, J. E. Olson, et al. Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging J. Clin. Oncol., September 1, 2009; 27(25): 4082 - 4088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Genson, C. E. Blane, M. A. Helvie, S. A. Waits, and T. L. Chenevert Effects on Breast MRI of Artifacts Caused by Metallic Tissue Marker Clips Am. J. Roentgenol., February 1, 2007; 188(2): 372 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Shah, S. K. Shah, and K. V. Greatrex Current Role of Magnetic Resonance Imaging in Breast Imaging: A Primer for the Primary Care Physician J Am Board Fam Med, November 1, 2005; 18(6): 478 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Newman and H. M. Kuerer Advances in Breast Conservation Therapy J. Clin. Oncol., March 10, 2005; 23(8): 1685 - 1697. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
